Nephrology clinical trials recruiting in Texas

53 recruiting nephrology trials match in Texas. Showing 20.

• Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell CarcinomaRecruiting

  Phase 1 / Phase 2 · Oncorena AB · Houston, Texas

• Post Market Study for VasQ, an External Support Implant for Arteriovenous FistulaRecruiting

  N/A · Laminate Medical Technologies · Houston, Texas

• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Recruiting

  Phase 3 · Boehringer Ingelheim · Indianapolis, Indiana

• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaRecruiting

  Phase 3 · Bayer · Palo Alto, California

• Diuretic Tuner Clinical Decision SupportRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• Prehabilitation for Kidney Transplant CandidatesRecruiting

  N/A · The Methodist Hospital Research Institute · Houston, Texas

• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF SystemRecruiting

  N/A · C. R. Bard · Dallas, Texas

• Kidney Health: Eat Well, Live WellRecruiting

  N/A · University of Texas at Austin · Houston, Texas

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruiting

  Phase 3 · AstraZeneca · Arlington, Texas

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseRecruiting

  Phase 2 · Novo Nordisk A/S · Ibaraki

• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.Recruiting

  Phase 2 · AstraZeneca · Arlington, Texas

• Study of BHV-1400 in IgA NephropathyRecruiting

  Phase 1 · Biohaven Therapeutics Ltd. · Houston, Texas

• Ferric Citrate and Chronic Kidney Disease in ChildrenRecruiting

  Phase 2 · University of California, Los Angeles · Dallas, Texas

• Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)Recruiting

  N/A · Amplifi Vascular, Inc. · Houston, Texas

• Shingrix in Renal Transplant RecipientsRecruiting

  Phase 3 · University of Colorado, Denver · Houston, Texas

• Sickle Cell Kidney BiorepositoryRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Recruiting

  Phase 2 / Phase 3 · CSL Behring · Austin, Texas

• Study of WAL0921 in Patients With Glomerular Kidney DiseasesRecruiting

  Phase 2 · Walden Biosciences · Houston, Texas

• Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.Recruiting

  Phase 3 · Novartis Pharmaceuticals · Dallas, Texas

• PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on HemodialysisRecruiting

  N/A · Merit Medical Systems, Inc. · Dallas, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.